BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//National Association of Attorneys General - ECPv5.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:National Association of Attorneys General
X-ORIGINAL-URL:https://www.naag.org
X-WR-CALDESC:Events for National Association of Attorneys General
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210616T140000
DTEND;TZID=America/New_York:20210616T150000
DTSTAMP:20210716T012357
CREATED:20210524T145424Z
LAST-MODIFIED:20210707T141443Z
UID:16309-1623852000-1623855600@www.naag.org
SUMMARY:Public Health and Legal Implications of Treatment Flexibilities for Substance Use Treatment During and After the COVID-19 Pandemic
DESCRIPTION:June 16\, 2021 at 2:00 – 3:00 PM EDT \nThe webinar will provide the attorney general community and other stakeholders with an update on increased flexibilities in treatment delivery (e.g.\, telehealth services) for substance use disorder treatment during and beyond the COVID-19 pandemic\, highlighting specific policy and legal considerations. Specifically\, the webinar will provide the following: \n\nAn overview of the federal-level policies that allow for flexibilities during the COVID-19 pandemic in telehealth services and take-home flexibilities for substance use treatment (including buprenorphine and methadone access).\nThe impacts of increased use of telehealth and take-home flexibilities on persons who use drugs and their providers (e.g.\, access to treatment\, rates of overdose).\nPolicy implications and other key considerations for the attorney general community.\n\nModerator\n\nAmanda Bowes\, MPH\, Health Policy Analyst\, National Association of Attorneys General (NAAG)\n\nSpeakers\n\nJenna Bluestein\, MPH\, Senior Associate\, Substance Use Prevention and Treatment Initiative\nBridget C.E. Dooling\, Research Professor\, George Washington Regulatory Studies Center\nLaura E. Stanley\, Senior Policy Analyst\, George Washington Regulatory Studies Center\nDr. Elizabeth A. Samuels\, Assistant Professor of Emergency Medicine\, Brown Emergency Medicine\, Alpert Medical School of Brown University\n\nRegistration\nThis webinar is free and open to the public. If you have any questions\, please contact Chelsey Shelton at cshelton@naag.org. \nRegistration deadline is Wednesday\, June 16 at noon EDT. \nIf you have created your NAAG account and receive an error message when trying to register\, please make sure you have entered your organization under your profile. You may need to wait up to 24 hours after your account is verified by your office before being able to register for this webinar. \nCLE Credit\nNAAG will apply for CLE for attendees eligible under CLE accrediting body guidelines.
URL:https://www.naag.org/event/public-health-and-legal-implications-of-treatment-flexibilities-for-substance-use-treatment/
LOCATION:Virtual
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.naag.org/wp-content/uploads/image-gallery/substance-abuse-opioids/substance-use-opioids-696188545-1200px.jpg
ORGANIZER;CN="Chelsey%20Shelton":MAILTO:cshelton@naag.org
END:VEVENT
END:VCALENDAR